The healthcare index jumped 1.8 per cent after the country approved Celltrion's experimental Covid-19 treatment for Phase 2/3 clinical trials.
The won ended at 1,160.3 per US dollar on the onshore settlement platform, up 1.22 per cent, the sharpest gain since late-March.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Sumber: BusinessTimes - 🏆 15. / 51 Baca lebih lajut »